Back
The Goldman Sachs Group Vs. PTC Therapeutics Industry Stock Comparison
Buy
68
GS
The Goldman Sachs Group
Last Price:
446.09
Seasonality Move:
2.39%
Sell
47
PTCT
PTC Therapeutics
Last Price:
34.68
Seasonality Move:
8.27%
Buy
68
The Goldman Sachs Group (GS)
is a Buy
Is The Goldman Sachs Group a Buy, Sell or Hold?
- The current The Goldman Sachs Group [GS] share price is $455.86. The Score for GS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- GS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $35.04. The Score for PTCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GS Stock Price Chart
What is The Goldman Sachs Group's stock price today?
-
The The Goldman Sachs Group share price today is $455.86
The current trend is moderately bearish and GS is experiencing slight buying pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $35.04
The current trend is moderately bearish and PTCT is experiencing slight buying pressure.
GS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.26 | Buy |
| Relative Strength Index (14 RSI): | 53.06 | Buy |
| Chaikin Money Flow: | 510834 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (449.79 - 461.51) | Buy |
| Bollinger Bands (100): | (390.39 - 449.77) | Buy |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 48.37 | Sell |
| Chaikin Money Flow: | 135092 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.32 - 37.86) | Sell |
| Bollinger Bands (100): | (26.42 - 35.08) | Buy |
GS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 454.7 | Buy |
| 20-day SMA: | 453.97 | Buy |
| 50-day SMA: | 445.69 | Buy |
| 200-day SMA: | 382.13 | Buy |
| 8-day EMA: | 455.38 | Buy |
| 20-day EMA: | 453.94 | Buy |
| 50-day EMA: | 443.77 | Buy |
| 200-day EMA: | 397.62 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.32 | Sell |
| 20-day SMA: | 36.32 | Sell |
| 50-day SMA: | 33.48 | Buy |
| 200-day SMA: | 27.73 | Buy |
| 8-day EMA: | 35.54 | Sell |
| 20-day EMA: | 35.73 | Sell |
| 50-day EMA: | 34.06 | Buy |
| 200-day EMA: | 31.81 | Buy |
The Goldman Sachs Group Earnings Growth & GS Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.26 per share, an increase next quarter of $1.14 per share, an increase this year of $13.97 per share, and an increase next year of $3.51 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.10 per share, an increase this year of $0.53 per share, and an increase next year of $2.08 per share.
The Goldman Sachs Group Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||